Pubblicazioni

A review of PCSK9 inhibition and its effects beyond LDL receptors

2016 - JOURNAL OF CLINICAL LIPIDOLOGY

Dixon, Dave L.; Trankle, Cory; Buckley, Leo; Parod, Eric; Carbone, Salvatore; Van Tassell, Benjamin W.; Abbate, Antonio

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

2015 - JOURNAL OF CLINICAL LIPIDOLOGY

Moriarty, Patrick M.; Thompson, Paul D.; Cannon, Christopher P.; Guyton, John R.; Bergeron, Jean; Zieve, Franklin J.; Bruckert, Eric; Jacobson, Terry A.; Kopecky, Stephen L.; Baccara Dinet, Marie T.; Du, Yunling; Pordy, Robert; Gipe, Daniel A.; ODYSSEY ALTERNATIVE, Investigators; Arca, Marcello